The AHA today urged President-elect Biden to provide strong federal leadership on the COVID-19 vaccine distribution and administration process, and it pledged to work with the incoming administration in expediting the administration of vaccines throughout the nation.

“This effort must be large and multifaceted, and it will require exceptional leadership and coordination to ensure none of the vaccine is wasted,” AHA said. “The most challenging task will be the work to keep the manufacturers, distributors, state and local officials, hospitals, pharmacies, other providers, schedulers, planners, site coordinators, data collectors, and others working as a team. We strongly believe the most important role for your administration will be to act as the quarterback for this massive undertaking.”

Read AHA’s letter for more detailed comments.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…